CD49a+CD8+ TRM cells produce IFN-γ to inhibit tumor progression in a melanoma mouse model, and alleviate inflammatory diseases (Cheuk et al., 2017; Le Floc’h et al., 2007; Murray et al., 2016). Here, CD8A is linked to neoplasm.